Autres langues Sanofi

Actions

SAN

FR0000120578

Produits pharmaceutiques

Temps réel Euronext Paris 12:41:14 24/09/2026			Varia. 5j.	Varia. 1 janv.
73,05 ^EUR	-0,08%		-2,92%	-11,68%

23/09	Les actions européennes négociées aux États-Unis sous forme d’American depositary receipts reculent dans les échanges de mercredi	MT
22/09	Vingt ans de Bourse européenne racontés par dix actions

Autres langues

10:51	Vent'anni di Borsa europea raccontati attraverso dieci titoli
23/09	European Equities Traded in the US as American Depositary Receipts Fall in Wednesday Trading
23/09	Veinte años de bolsa europea contados a través de diez valores
23/09	Twenty years of Europe's stock market told through ten stocks
22/09	European Pharma Leaders Push for National Reforms to Boost Investment
22/09	European drugmakers call for faster trials, more spending to compete with US, China
21/09	Pharma sector doubles down on AI to slash costs, timelines
18/09	Sanofi's Rabies Vaccine VaxRabeo Recommended for EU Approval
17/09	Bavarian Nordic Names New CEO/President
16/09	Sanofi Inaugurates Charles Best Building Flu Vaccine Manufacturing Facility in Toronto
16/09	Sanofi Opens New Flu Vaccine Facility in Toronto
16/09	Cheplapharm hat nach Sanofi-Einstieg Appetit auf mehr
16/09	Sanofi inaugurates new flu vaccine facility, Canada's largest biomanufacturing investment
16/09	Pharma sector doubles down on AI to slash costs, timelines
14/09	Sanofi and Cheplapharm Create Strategic Partnership in Mature Medicines
14/09	European Stocks Close Mixed in Monday Trading; ECB Rates Could Rise as Energy Costs Fuel Inflation
14/09	Cheplapharm aus Greifswald und Sanofi vor Milliarden-Deal
14/09	Französischer Pharmariese Sanofi steigt bei deutscher Cheplapharm ein
14/09	Sanofi beteiligt sich an deutscher Cheplapharm
14/09	Sanofi to Acquire 26.4% Stake in Cheplapharm
14/09	Sanofi to Take Stake in Cheplapharm in Swap for Drug Portfolio, Manufacturing Sites
14/09	Sanofi Plans Strategic Partnership to Transfer Mature Medicines, Sites to Cheplapharm
14/09	Sanofi and Cheplapharm to create new strategic partnership in mature medicines
14/09	CHEPLAPHARM Arzneimittel GmbH signed a letter of intent to acquire 20 mature medicines and three manufacturing sites worldwide from Sanofi.
09/09	RBC Launches Sanofi Coverage at Sector Perform Amid Management Turnaround, 'Light' Near-term Catalysts